【创新鼻内药物企业】ORAGENICS INC（OGEN）美股招股说明书 S-1（2025-06-30修订版）（英文版）（8页）.pdf

1、S-1/A 1 forms-1a.htm S-1/A As filed with the Securities and Exchange Commission on June 30,2025 Registration No.333-288225 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 Amendment No.1toFORM S-1 REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933 ORAGENICS,INC.(Exact name of r

2、egistrant as specified in its charter)Florida 59-3410522(State or other jurisdiction ofincorporation or organization)(I.R.S.EmployerIdentification No.)1990 Main Street,Suite 750Sarasota,Florida 34236(813)286-7900(Address,including zip code,and telephone number,including area code,of principal execut

3、ive offices)Janet Huffman,Chief Executive Officer and Chief Financial OfficerOragenics,Inc.1990 Main Street,Suite 750Sarasota,Florida 34236(813)286-7900(Name,address,including zip code,and telephone number,including area code,of agent for service)With copies to:Mark A.Catchur,Esq.Julio C.Esquivel,Es

4、q.Shumaker,Loop&Kendrick,LLP101 East Kennedy BoulevardSuite 2800Tampa,Florida 33602Telephone:(813)229-7600Facsimile:(813)229-1660 Ralph V.DeMartino,Esq.Marc Rivera,Esq.ArentFox Schiff LLP1717 K Street NWWashington,DC 20006Telephone:(202)350-3643Facsimile:(202)857-6395 Approximate date of commencemen

5、t of proposed sale to the public:From time to time after this registration statement becomeseffective.If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 underthe Securities Act of 1933,other than securities offered only in c

6、onnection with dividend or interest reinvestment plans,check thefollowing box.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,please checkthe following box and list the Securities Act registration statement number of the earlier